Asthma continues to be one of the most frequently managed chronic respiratory conditions across clinical settings. For hospitals, pharmacies, and healthcare distributors, the requirement for dependable, clinically compliant asthma formulations remains a priority. Steris Healthcare Pvt. Ltd. delivers a specialized range of asthma medicines that are designed to support acute symptom relief as well as long-term maintenance therapy.

This professionally curated review covers only the verified asthma medicines from Steris Healthcare and integrates the market-focused keywords boldly where required.

Asthma Care by Steris Healthcare

Steris Healthcare offers inhalers, dry-powder capsules, and oral therapies tailored for varying stages of asthma management. These formulations play a significant role in offering the best asthma medicine in india for both adult and chronic-care segments.

1. Asthma Medicine Inhalers

INH BUDEPRESS 400 (Budesonide + Formoterol)

This dual-therapy inhaler provides long-term maintenance for persistent asthma. Its anti-inflammatory and long-acting bronchodilator combination enables sustained relief, making it a strong contender among the best asthma medicine options for chronic management.

INH BUDEPRESS 200 (Budesonide + Formoterol)

A suitable choice for mild to moderate asthma. Its lower strength allows clinicians to prescribe step-down therapy while maintaining effective symptom control. This product contributes significantly to the clinical demand for the best asthma medicine for adults requiring balanced maintenance.

INH AIRFLOW 250 (Fluticasone + Salmeterol)

An advanced inhaler formulated for adult patients with repeated symptoms. It stabilizes the airway over long durations and ensures consistent therapeutic outcomes, reinforcing its presence in the segment of the best asthma medicine in india for hospital-based respiratory care.

INH AIRFLOW MAX F250 (Fluticasone + Formoterol)

A specialized inhaler engineered for enhanced efficacy in moderate to severe asthma. Its precision delivery supports healthcare providers in offering predictable long-term asthma control.

2. Asthma Medicine Capsules for Inhalation

BUDEPRESS FORTE 400 (Budesonide + Formoterol)

This dry-powder capsule formulation is designed for deep lung deposition. It delivers dependable results in patients requiring inhalation-based maintenance therapy. Its clinical performance aligns with the growing preference for the best asthma medicine for adults needing consistent airway stabilization.

R/C BUDEPRESS 400 (Budesonide + Formoterol)

A reliable maintenance therapy solution that enables controlled dosing and enhanced bronchodilation. Healthcare facilities widely adopt this formulation for chronic asthma cases due to its strong therapeutic profile.

R/C AIRFLOW MAX F250 (Formoterol + Fluticasone)

This respirable capsule supports dual-action asthma control. It provides both bronchodilation and inflammation reduction, offering a balanced solution for long-term symptom management.

R/C AIRFLOW 100 (Salmeterol + Fluticasone)

A maintenance capsule formulated for ongoing symptom control and reduced exacerbation risk. It helps institutions deliver standardized care across large patient groups.

R/C AIRFLOW 500 (Salmeterol + Fluticasone)

A higher-strength alternative suitable for patients requiring stronger dosing. Its optimized delivery profile supports deep airway penetration, making it useful for advanced asthma management.

FLUTICATONE VILO 200 (Fluticasone Furoate + Vilanterol)

A once-daily DPI formulation offering ultra-long bronchodilation. Its dosing convenience enhances patient adherence, which is vital for chronic asthma treatment pathways.

FLUTICATONE VILO 100 (Fluticasone Furoate + Vilanterol)

A lower-strength variant designed for mild to moderate asthma. It supports predictable daily management and improved lung function stability.

3. Asthma Medicine Tablets

MONTELUKE AB (Montelukast 10 mg + Acebrophylline 200 mg SR)

A well-established oral formulation extensively used for airway inflammation control. This combination tablet provides mucoregulation, leukotriene inhibition, and bronchodilation. It is among the practical, high-demand oral options selected by healthcare facilities when prescribing the best asthma medicine for allergy-triggered or chronic asthma cases.

Why Steris Healthcare’s Asthma Portfolio Meets B2B Requirements

1. Clinically Validated Compositions

All formulations feature globally established APIs known for safety, efficacy, and consistent therapeutic outcomes.

2. Broad Treatment Coverage

The presence of inhalers, capsules, and oral tablets ensures availability across all patient categories—from mild asthma to complex chronic conditions.

3. High Manufacturing Standards

Every product is produced under stringent regulatory guidelines, ensuring optimal purity, stability, and uniformity.

4. Reliable Supply for Healthcare Partners

Steris Healthcare ensures timely availability, making it a dependable partner for hospitals, pharmacies, and distributors looking for the best asthma medicine in india supported by quality assurance.

Conclusion

Steris Healthcare Pvt. Ltd. provides a robust, clinically focused asthma medicine portfolio designed for modern respiratory management. Each product included in this review is verified specifically for asthma and contributes to building a reliable therapeutic pathway for adults and chronic-care patients. By offering inhalers, capsules, and tablets, Steris Healthcare supports healthcare institutions in delivering the best asthma medicine, especially for those seeking the best asthma medicine for adults in India’s growing respiratory care sector.